The report highlights Telix's commitment to ESG principles and its progress in 2021. The company highlights its focus on patient safety and quality, as well as its efforts to reduce its environmental impact and promote diversity and inclusion within the organization. The report also details Telix's commitment to good governance practices, including its expanded Audit and Risk Committee to oversee ESG matters.
Issuing Company Telix Pharmaceuticals Limited
Report Type Sustainability Report
Report Language EN
Report Filesize 4.2 MB
No. of Pages 5 pages
Reporting periodUnknown
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards Unknown
Materiality Assessmenttrue
